Sharone Shackleford is Avila’s Caregiver of the Month for January, 2022!

Avila is delighted to share that Sharone Shackleford is our Caregiver of the Month for January 2022!  Sharone joined Avila in early 2018.  During her tenure, she has been an integral part of the team serving countless clients. Sharone is dedicated and hard-working, and exhibits a very strong level of commitment to her clients.  She has especially gone above and beyond throughout the pandemic to make sure clients get the care they need.  We are so thankful to have Sharone on the Avila team!

Sharing is caring!

Life, Liberty and Chemistry- Avila Client Margaret Sellmayer

May 11, 2022

Margaret Sellmayer has abundant wisdom and a quick wit to share with Avila in this feature story. A renowned chemist for decades, loyal to her family and friends, and a woman of deep faith, at 92 years old, Margaret is a remarkable Avila Home Care Client, as well as long-time Oak Crest Senior Living Community resident and an inductee into the Maryland Senior Citizens Hall of Fame.

Margaret shares, “The secret to a long life is (1) faith in God and (2) a positive attitude- I have a lot to be grateful for; God is good!”

Read More...

The Benefits of Maintaining an Active Social Life While Social Distancing

June 12, 2020

In the midst of the novel coronavirus, leaning on each other for strength and comfort is difficult when individuals must practice social distancing. Lack of social contact is difficult for anyone. While we fight to overcome this pandemic, adapting to new ways of maintaining an active social life can bring hope and comfort in an…

Read More...

Daily Low-Dose Aspirin Shown to Have No Effect on Healthy Life Span in Seniors, Study Shows

November 21, 2018

A recent clinical trial supported by the National Health Institute (NIH) found that the daily low-dose use of the common anti-inflammatory drug, aspirin, did not prolong healthy and independent living—specifically, a life free of dementia or persistent physical disability. These findings, collected in a clinical trial from ASPirin in Reducing Events in the Elderly (ASPREE),…

Read More...